FINWIRES · TerminalLIVE
FINWIRES

Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35

-- Centessa Pharmaceuticals ADR (CNTA) has an average rating of Hold and mean price target of $42.55, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles